Risankizumab for Fibrostenotic Crohn's Disease Treatment
Clinical trial NCT07177118 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07177118
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-20
- Primary completion
- 2028-06-20
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.